312 related articles for article (PubMed ID: 29316976)
1. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.
Kim WW; Ha TK; Bae SK
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
[TBL] [Abstract][Full Text] [Related]
4. BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis.
Sargent R; LiVolsi V; Murphy J; Mantha G; Hunt JL
Endocr Pathol; 2006; 17(3):235-41. PubMed ID: 17308360
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
6. Role of chronic lymphocytic thyroiditis in central node metastasis of papillary thyroid carcinoma.
Paulson LM; Shindo ML; Schuff KG
Otolaryngol Head Neck Surg; 2012 Sep; 147(3):444-9. PubMed ID: 22547555
[TBL] [Abstract][Full Text] [Related]
7. Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma.
Kim YS; Kim JS; Bae JS; Park WC
World J Surg Oncol; 2013 May; 11():99. PubMed ID: 23687957
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.
Jeong JS; Kim HK; Lee CR; Park S; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
J Korean Med Sci; 2012 Aug; 27(8):883-9. PubMed ID: 22876054
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.
Yoon YH; Kim HJ; Lee JW; Kim JM; Koo BS
Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1013-7. PubMed ID: 21822854
[TBL] [Abstract][Full Text] [Related]
12. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
13. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS
Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294
[TBL] [Abstract][Full Text] [Related]
14. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.
Marotta V; Guerra A; Zatelli MC; Uberti ED; Di Stasi V; Faggiano A; Colao A; Vitale M
Clin Endocrinol (Oxf); 2013 Nov; 79(5):733-8. PubMed ID: 23469895
[TBL] [Abstract][Full Text] [Related]
15. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis.
Consorti F; Loponte M; Milazzo F; Potasso L; Antonaci A
Eur Surg Res; 2010; 45(3-4):333-7. PubMed ID: 21051899
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer.
Sakiz D; Sencar ME; Calapkulu M; Ozturk Unsal I; Aktas L; Ucan B; Ozbek M; Cakal E
Endocr Pract; 2021 Dec; 27(12):1199-1204. PubMed ID: 34293511
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
19. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.
Lee I; Kim HK; Soh EY; Lee J
World J Surg; 2020 May; 44(5):1506-1513. PubMed ID: 31915977
[TBL] [Abstract][Full Text] [Related]
20. Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.
Yoon S; An YS; Lee SJ; So EY; Kim JH; Chung YS; Yoon JK
Medicine (Baltimore); 2015 Dec; 94(48):e2063. PubMed ID: 26632889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]